MD&M East

FDA Approves First MR-Conditional CRT-D Devices

Medtronic announced Friday that FDA has approved the the first MR-conditional cardiac resynchronization therapy defibrillators (CRT-Ds) for the treatment of heart failure in the U.S. The Medtronic ...
Medscape

How LBB Area Pacing Compares to Standard CRT

Newer pacing method matched standard cardiac resynchronization therapy with respect to clinical outcomes in the first ...
Healio

CRT devices, His bundle pacing, reducing complications focus of new ESC pacing guideline

Please provide your email address to receive an email when new articles are posted on . Among the features of the new European Society of Cardiology guideline on pacing and cardiac resynchronization ...
Healio

FDA designates recall of ICD, CRT devices as class I

Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...

A new heart failure pacing option may reduce repeat surgeries and shorten implant procedures

Left bundle branch area pacing is an effective and practical strategy for cardiac resynchronization, according to a ...
Reuters

Medtronic device helps in earlier heart failure

CHICAGO, Nov 14 (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that ...
abc27

FDA Approves WiSE® System, World's First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT

Every once in a while, a breakthrough doesn't just advance medicine—it changes the conversation entirely. SUNNYVALE, Calif., April 17, 2025 /PRNewswire/ -- EBR Systems, Inc. (ASX: EBR) has received ...
Business Wire

FDA Grants EBR Systems Breakthrough Device Designation Status for the WiSE Cardiac Resynchronization Therapy (CRT) System

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) ...
EurekAlert!

CRT consensus set to standardize and improve care for patients worldwide

Munich, Germany – August 28 2012: Recommendations for the practical management of CRT patients have been set out for the first time in an international consensus statement on cardiac resynchronization ...
Medscape

First Experience With Completely Leadless CRT

Totally leadless cardiac resynchronization therapy (CRT) combining the Micra transcatheter pacing system and a WiSE-CRT system was feasible and associated with significant acute QRS reduction in a ...
TCTMD

Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function

MINNEAPOLIS - Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization ...
Nature

CARE-HF extension demonstrates a sustained benefit of CRT

The Cardiac Resynchronization in Heart Failure (CARE-HF) trial investigated the benefits of cardiac resynchronization therapy (CRT) in patients with persistent moderate or severe symptoms of heart ...